- Report
- August 2025
- 197 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- August 2025
- 192 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- August 2025
- 190 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- August 2025
- 187 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- January 2025
- 200 Pages
Global
From €2198EUR$2,490USD£1,918GBP
- Report
- September 2025
- 250 Pages
Global
From €3963EUR$4,490USD£3,459GBP
- Report
- September 2025
- 250 Pages
Global
From €3963EUR$4,490USD£3,459GBP
- Report
- April 2025
- 200 Pages
Global
From €3963EUR$4,490USD£3,459GBP
- Report
- April 2025
- 200 Pages
Global
From €3963EUR$4,490USD£3,459GBP
- Report
- February 2025
- 200 Pages
Global
From €3963EUR$4,490USD£3,459GBP
- Report
- February 2025
- 200 Pages
Global
From €3963EUR$4,490USD£3,459GBP
- Report
- June 2025
- 200 Pages
Global
From €2462EUR$2,789USD£2,149GBP
- Report
- June 2025
- 400 Pages
Global
From €4369EUR$4,949USD£3,813GBP
- Report
- July 2025
- 270 Pages
Global
From €4409EUR$4,995USD£3,848GBP
- Report
- January 2025
- 210 Pages
Global
From €4409EUR$4,995USD£3,848GBP
- Report
- May 2025
- 200 Pages
Asia Pacific
From €2198EUR$2,490USD£1,918GBP
- Report
- April 2023
- 175 Pages
Global
From €5207EUR$5,899USD£4,545GBP
- Report
- March 2025
- 200 Pages
India
From €2198EUR$2,490USD£1,918GBP
- Report
- June 2024
- 238 Pages
Global
From €7018EUR$7,950USD£6,125GBP
- Report
- February 2023
- 27 Pages
Global
€10813EUR$12,250USD£9,437GBP

Doxycycline is an antibiotic used to treat a variety of bacterial infections, including those caused by immune disorders. It is a tetracycline antibiotic, which works by inhibiting the growth of bacteria. It is commonly used to treat infections caused by Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae. It is also used to treat Lyme disease, acne, and other skin conditions. Doxycycline is available in both oral and intravenous forms.
The doxycycline market is highly competitive, with many companies offering generic and branded versions of the drug. Companies such as Pfizer, Merck, and Teva Pharmaceuticals are some of the major players in the market. Other companies include Mylan, Sandoz, and Sun Pharmaceuticals. Show Less Read more